ClinicalTrials.Veeva

Menu

Mindfulness and Self-compassion Focussed Walking (MSCW)

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Unknown

Conditions

Breast Cancer
Fatigue

Treatments

Behavioral: Walking training
Behavioral: Mindfulness and Self-Compassion focussed exercises during walking training

Study type

Interventional

Funder types

Other

Identifiers

NCT04193644
MSCW2019

Details and patient eligibility

About

This research study is evaluating the effects of two training programs (1. Walking, 2. Mindfulness and Self-compassion focussed Walking) on tumor-specific symptoms of fatigue in women with breast cancer undergoing chemo- and/or radiotherapy.

Full description

This randomized research study is evaluating the effects of two training programs (1. Walking, 2. Mindfulness and Self-compassion focussed Walking (MSCW)) on tumor-specific symptoms of fatigue in women with breast cancer undergoing chemo- and/or radiotherapy. The results of both groups are compared with each other and with those of a control group.

The MSCW program combines endurance based physical activity in the form of medically controlled walking, as well as standardized, evidence-based mindfulness exercise elements in a training program.

The participants of both active groups (Walking and MSCW) practice for 12 weeks, once a week for 60 minutes under the guidance of a trainer in a group and 2 additional times (60 minutes each) independently at home.

The purpose of this study is to prevent a sharp decline in quality of life due to fatigue symptoms by participating in the MSCW training program.

A total of 135 participants will be included in the study. All participants are followed for 1 year.

Enrollment

135 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with breast cancer who have started antineoplastic therapy (chemotherapy / radiotherapy).
  • Age ≥18 years
  • The patient must be able to perform the study intervention (physically and psychologically).
  • oral and written consent to participate in the study.

Exclusion criteria

  • distant metastases
  • Severe mental and / or additional organic illnesses
  • Clinically relevant cardiac arrhythmias or angina pectoris
  • Severe pulmonary disease
  • inadequate walking ability or gait disturbance (including neurological deficits, endoprosthesis supply that lead to gait insecurity)
  • regular meditation practice (several times a week)
  • Planned start of meditation, relaxation, MBSR, yoga, Qi Gong courses over the next 24 weeks.
  • Participation in other intervention studies on walking or meditation
  • Insufficient knowledge of the German language

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

135 participants in 3 patient groups

Walking-Group
Active Comparator group
Description:
Participants in this group walk 45 minutes 3 times a week (plus 15 minutes of warm up and cool-down) in a moderate intensity range (64-76% HRmax).
Treatment:
Behavioral: Walking training
Mindfulness and Self-Compassion focussed Walking-Group
Experimental group
Description:
Participants in this group walk 45 minutes 3 times a week (plus 15 minutes of warm up and cool-down) in a moderate intensity range (64-76% HRmax) and additionally practice mindfulness exercises and self-compassion exercises during the 60 minutes.
Treatment:
Behavioral: Mindfulness and Self-Compassion focussed exercises during walking training
TAU-Group
No Intervention group
Description:
Participants in this group receive no intervention.

Trial contacts and locations

2

Loading...

Central trial contact

Andreas Ströhle, Prof.; Yves L. Steininger, M.Sc. M.Sc.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems